Pi Industries Limited · NSE:PIIND

Pi Industries — Q3 FY25 Earnings Presentation

27 slides from Pi Industries's earnings presentation, Feb 6, 2025

  1. Slide 1: Exchange cover letter: press release on Q3 and nine months results

    PI External Inspired by Science PIIL:SEC:NSE/BSE:79/2024-25 February 06, 2025 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Deptt. Exchange Plaza, Plot No. C/1, G-Block PJ Towers, 25th Floor, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai – 400

  2. Slide 2: PI Industries Ltd. Investor Presentation Q3 FY25 Result

    Inspired by Science PI Industries Ltd. Investor Presentation Q3 FY25 Result 1

  3. Slide 3: Agenda

    Inspired by Science AGENDA CDR India Siddharth Rangnekar • Consolidated Financial Performance siddharth@cdr-india.com Nishid Solanki • Key Updates nishid@cdr-india.com Tel: +91 22 6645 1221 /1209 • Business Model and Strategy Fax: +91 22 6645 1213 • ESG Credentials PI Industries Limited • Rewards &

  4. Slide 4: Stable Performance amidst Challenging Market Dynamics

    Stable Performance amidst Challenging Market Dynamics… Reflecting strong business model and disciplined execution Inspired by Science Revenue EBITDA PAT Figures in Rs. Million *Q3FY25 19,008 0.2% 5,122 8% 3,727 17% *9MFY25 61,907 4% 17,264 9% 13,297 1% Commercialised Cash flow from Trade working 6 n

  5. Slide 5: Consolidated revenue and margins maintained in Q3

    Consolidated revenue and margins maintained in Q3 Strong recovery of Domestic revenues Inspired by Science - - - - - - - - - - - - - - - - - - - - - - - Fig in Rs. Million Q3FY24 Q3FY25 % YOY ▪ Overall flat revenue (3-year Q3 CAGR 12%). ▪ ~2% growth in Agchem Exports (Volume up ~5%) and growth of ne

  6. Slide 6: Growth of new products remained key feature of 9MFY25

    Growth of new products remained key feature of 9MFY25… ..offsetting inventory pressure of legacy products Inspired by Science - - - - - - - - - - - - - - - - - - - - - - - Fig in Rs. Million 9MFY24 9MFY25 % YOY ▪ Overall 4% Y-o-Y revenue growth (3-year 9MFY25 CAGR 17%) ▪ ~9% growth in Agchem Exports

  7. Slide 7: Free cash generation on a strong balance sheet driving growth investments

    Free cash generation on a strong balance sheet … driving growth investments Inspired by Science Fig in Rs. Million Dec-23 Mar-24 Dec-24 Highlights of 9MFY25 Shareholders Fund 84,508 87,310 98,660 Non Current Liabilities 3,082 3,224 3,406 Long term borrowings 697 617 456 ▪ Increase in Networth by Rs.

  8. Slide 8: World-class R&D set-up delivering innovative and disruptive solutions

    World-class R&D set-up delivering innovative and disruptive solutions ,.,Y ysc·1ence State-of-the-art R&D Labs at 4 locations ~ - R&D NABL ISO17025 and GLP certified New ICP-OES 1st Indian company to receive approval from International 700+ Scientists 60+ projects at Organization for 200+ Doctorates

  9. Slide 9: Agchem CSM, a global leader, backed by strong technological strengths

    Agchem CSM, a global leader, backed by strong technological strengths • Technology pioneer 14 with technological and IP based interventions in global ✓ ISO-certifications contract manufacturing ✓ Golden Batch Tool ✓ 2 dedicated scale-up • 15 Fully automated Multipurpose 2 Plants (MPPs) facilities at

  10. Slide 10: Over 6 decades of bringing innovation to Indian farmers

    Over 6 decades of bringing innovation to Indian farmers and creating market leader brands … Crop S crop olutions Solutions HORTICULTURE RICE SOYBEAN WHEAT CHILLI COTTON CORN 9

  11. Slide 11: Momentum for launching new innovative products continued

    Momentum for launching new innovative products continued... FY23 Provide® Dinoace Sectin® Brofreya® Ultimare® Taurus® Tomatough® Herbicide for Cotton Dual action Combination Revolutionary Novel Model of Nematicide for Biological product insecticide for Fungicide Insecticide action vegetable crops fo

  12. Slide 12: Deep engagement with farmers and channels with innovative approaches

    Deep engagement with farmers and channels with innovative approaches El Inspired by Science Farmer Channel Precision Connect Connect Farming Services • 5 product launches • 50,000+ retailer connect • 10,000+ farmers served • 10 major product campaigns across multiple marketing across 600+ villages w

  13. Slide 13: Biologicals, our passion for over 2 decades

    Biologicals, our passion for over 2 decades... Inspired by Science A comprehensive smart biological portfolio being built AMINOGROW SIAPTON® RAPIGRO Lq. RAPIGRO 0 ARMATURA® over the last 20 years ACTIV __.. GR. llilil BIOVITA® PIILIN® BIOVITA® JB07 GRANULES LIQUID Biologicals revenue fastest growing

  14. Slide 14: Harpin Protein biostimulants technology

    Harpin Protein History Unique Biostimulants technology Class of proteins, harpins, that function 0 in nature as warning compounds 1 HARPIN⍺β BINDS TO TRIGGERS GROWTH Derived from “Hypersensitive Response PLANT CELL AND DEFENCE 0 4 ACTIVE DOMAINS & Pathogenicity N” gene (HrpN) RECEPTORS RESPONSE TECH

  15. Slide 15: PIHS: Build-up of a differentiated CRDMO platform

    PIHS: Build-up of a differentiated CRDMO platform with high quality of Talent, Assets, Processes and Customer Portfolio '"'fySc,·l ence TALENT CUSTOMER ASSETS Initiated global pharma and biotech companies visit to newly refurbished facilities at Hyderabad and Jaipur Invested capex of Rs Dr. Ramesh S

  16. Slide 16: PIHS: FY25 financials reflect transition to new business model

    PIHS: FY25 financials reflect transition to new business model and ________________ ,. f;l development spend Fig in Rs. Million Revenue Gross Margin Overheads ---- Q3FY24 1,273 51% 650 Q1FY25 253 42% 611 Q2FY25 411 59% 879 Q3FY25 637 48% 657 ▪ Sequential Q-o-Q revenue recovery in Q3FY25 ▪ Key CDMO o

  17. Slide 17: Transitioning from Ag Science to Life Sciences company

    Transitioning from Ag Science to Life Sciences company 350 300 300+ 250 250+ Global market ($ bn) 200 Pharma 150 From pure play Agrochemicals CSM & CRDMO 100 50 Distribution opportunity of ~15-20 Bn 0 2021 2022 2023 2024 2025 2026 2027 2028 2021 Discovery Pre-clinical dev. Clinical dev. CMO 2028 of

  18. Slide 18: Outlook remains positive amid transitory industry headwinds

    Outlook remains positive amid transitory industry headwinds Inspired by Science • Demand expected to improve in second half of CY25 CSM Export: • Continued scale-up of products commercialized over the last 3-years Technology focused approach • Capacity expansion in line with plan to drive incrementa

  19. Slide 19: PI the company

    PI the company Inspired by Science known for over 2 decades to be the Top wealth creator . . . An organization that is committed to excellence in whatever it does . . . “Outshines competitors in delivering business needs of the customers by unlocking value & fearlessly reinventing ourselves ” A Trus

  20. Slide 20: Our Global Presence

    Our Global Presence Inspired by Science Germany India Amsterdam Ir. Milan Q Q Raleigh Japan 1i:.I Alabama Q China .·, .... Q 1i:.I r.:i Q ..:r 1i:l ..:r r.:i er India Q Ii:) Sao Paulo Offices in India, US, Italy, Japan, er Ii:) Netherlands, China, Brazil and ..:r Germany 0 @ Registered Office ~ Corpor

  21. Slide 21: Values and strategic pillars

    Inspired by Science ~ “Lead with science, technology and human ingenuity to create transformative solutions in life sciences” Courageous .~· ~ Curious Creative -w- Caring ~ ~ Think /3ofd, act with IHte5rity /)uert/o,. conventional wisdom, Di/f11r11.,fio.te, Col/o.l,oro.te, Be Tr=r,,..,-,..t, build T

  22. Slide 22: Agchem business model built on respect for IP and established relationships

    Agchem Business model built on the principles of respect for IP and ------------------------------------ ,.t ;l established relationships Leading Agchem Distribution India’s largest CRAMS Company Company in India with Domestic Brand Market with majority revenue from Exports Market leading market sha

  23. Slide 23: Multipronged strategy to sustain growth momentum

    Multipronged strategy to sustain the growth momentum backed by multiple growth engines & aggressive M&A Market • Expansion Build Explore and exploit • Creation Customer Intimacy untapped chemistry • Segments Product & areas Deepening our technological capabilities to open new Customer-centric servic

  24. Slide 24: PI in the S&P Global Sustainability Yearbook 2024

    PI in the S&P Global Sustainability Yearbook 2024 Ranked among the Top 3 percentile of ESG Rated companies globally… Our 2025 Goal SDG alignment Our achievement Our 2025 Goal SDG alignment Our achievement Carbon emissions intensity in terms of (from FY2021) (from FY2021) revenue from operations (₹ m

  25. Slide 25: Our CSR efforts focused on community welfare & environment

    Our CSR efforts focused on community welfare & environment CSR policy directed towards inclusive development that creates value for the society a Inspired by Science Education Health & Women & Skill Environment Hygiene Empowerment Development Sustainability Health & wellness support for rural • Prog

  26. Slide 26: Rewards and Recognition

    Rewards and Recognition a Inspired by Science Most Promising Company Barclays Private Client Most Preferred of the Year Hurun India Award 2024 Workplace 2024-25 by CNBC TV18 India Business for Leadership Excellence and Vision by Marksmen Daily Leader Awards (IBLA) ... IHDIA'S t ........ ~ India’s Be

  27. Slide 27: Thank You

    Inspired by Science Thank You 26

PI Industries — Q3 FY25 Earnings Presentation on 6ix